Literature DB >> 13955118

The Stevens-Johnson syndrome. Ocular prognosis and treatment.

G M HOWARD.   

Abstract

Entities:  

Keywords:  BLINDNESS; CONJUNCTIVITIS; CORNEAL OPACITY; PHOTOSENSITIZATION; STEVENS-JOHNSON SYNDROME

Mesh：

Year:  1963        PMID： 13955118

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  10 in total

1.  Conjunctival inflammation in the chronic phase of Stevens-Johnson syndrome.

Authors:  S Kawasaki; K Nishida; C Sotozono; A J Quantock; S Kinoshita
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

Review 2.  Stevens-Johnson syndrome: a review of the literature.

Authors:  V J Stitt
Journal:  J Natl Med Assoc       Date:  1988-01       Impact factor: 1.798

Review 3.  Erythema multiforme: clinical spectrum and immunopathogenesis.

Authors:  J A Kazmierowski; K D Wuepper
Journal:  Springer Semin Immunopathol       Date:  1981-06

4.  Modern treatment of severe "shrinkage of the conjunctiva".

Authors:  R F Taylor
Journal:  Br J Ophthalmol       Date:  1967-01       Impact factor: 4.638

5.  Epithelial hyperproliferation and transglutaminase 1 gene expression in Stevens-Johnson syndrome conjunctiva.

Authors:  K Nishida; K Yamanishi; K Yamada; A Dota; S Kawasaki; A J Quantock; S Kinoshita
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

6.  Comprehensive approach to ocular consequences of Stevens Johnson Syndrome - the aftermath of a systemic condition.

Authors:  Geetha Iyer; Bhaskar Srinivasan; Shweta Agarwal; Seema Kamala Muralidharan; Sumathi Arumugam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-29       Impact factor: 3.117

Review 7.  Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Elizabeth Shay; Ahmad Kheirkhah; Lingyi Liang; Hossam Sheha; Darren G Gregory; Scheffer C G Tseng
Journal:  Surv Ophthalmol       Date:  2009-08-21       Impact factor: 6.048

8.  A case of bortezomib (Velcade)-induced Stevens-Johnson syndrome confirmed by patch test.

Authors:  Gil-Soon Choi; Ho Sup Lee; Hee-Kyoo Kim
Journal:  Asia Pac Allergy       Date:  2021-04-21

9.  Orbito-oculoplastic diseases in lagos: a 4-year prospective study.

Authors:  Bolanle G Balogun; Bola J Adekoya; Modupe M Balogun; Olufunke A Ehikhamen
Journal:  Middle East Afr J Ophthalmol       Date:  2014 Jul-Sep

10.  Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis.

Authors:  Yamato Yoshikawa; Mayumi Ueta; Hiromi Nishigaki; Shigeru Kinoshita; Tsunehiko Ikeda; Chie Sotozono
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.